- Home
- HYFT vs ONCY Comparison
HYFT vs ONCY Comparison
Compare HYFT & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYFT
- ONCY
- Stock Information
- Founded
- HYFT 1983
- ONCY 1998
- Country
- HYFT United States
- ONCY Canada
- Employees
- HYFT N/A
- ONCY N/A
- Industry
- HYFT Biotechnology: Pharmaceutical Preparations
- ONCY Pharmaceuticals and Biotechnology
- Sector
- HYFT Health Care
- ONCY Health Care
- Exchange
- HYFT Nasdaq
- ONCY Nasdaq
- Market Cap
- HYFT 80.8M
- ONCY 89.7M
- IPO Year
- HYFT 2017
- ONCY 1999
- Fundamental
- Price
- HYFT $1.69
- ONCY $1.38
- Analyst Decision
- HYFT
- ONCY Strong Buy
- Analyst Count
- HYFT 0
- ONCY 5
- Target Price
- HYFT N/A
- ONCY $5.00
- AVG Volume (30 Days)
- HYFT 1.5M
- ONCY 1.5M
- Earning Date
- HYFT 09-15-2025
- ONCY 11-11-2025
- Dividend Yield
- HYFT N/A
- ONCY N/A
- EPS Growth
- HYFT N/A
- ONCY N/A
- EPS
- HYFT N/A
- ONCY N/A
- Revenue
- HYFT $18,214,531.00
- ONCY N/A
- Revenue This Year
- HYFT $19.93
- ONCY N/A
- Revenue Next Year
- HYFT $32.15
- ONCY N/A
- P/E Ratio
- HYFT N/A
- ONCY N/A
- Revenue Growth
- HYFT 18.33
- ONCY N/A
- 52 Week Low
- HYFT $0.27
- ONCY $0.33
- 52 Week High
- HYFT $3.25
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- HYFT N/A
- ONCY 60.64
- Support Level
- HYFT N/A
- ONCY $1.20
- Resistance Level
- HYFT N/A
- ONCY $1.47
- Average True Range (ATR)
- HYFT 0.00
- ONCY 0.08
- MACD
- HYFT 0.00
- ONCY 0.00
- Stochastic Oscillator
- HYFT 0.00
- ONCY 58.06
About HYFT MindWalk Holdings Corp. Common Stock
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.